Viewing Study NCT04677361


Ignite Creation Date: 2025-12-24 @ 12:51 PM
Ignite Modification Date: 2025-12-27 @ 9:17 PM
Study NCT ID: NCT04677361
Status: WITHDRAWN
Last Update Posted: 2021-10-08
First Post: 2020-12-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Sponsor: Fox Chase Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module